The prevalence of<unk>  is estimated to be 2.8 - 13.7 per 100.000 individuals worldwide. In the United States, the incidence of<unk>  is 0.11 per 100,000 indvidual.<unk>  affects men and women equally.
Acromegaly epidemiology and demographics
Hypoaldosteronism epidemiology and demographics
Hyperaldosteronism epidemiology and demographics
Insulinoma staging
Pheochromocytoma epidemiology and demographics
Autoimmune polyendocrine syndrome epidemiology and demographics
Adrenal insufficiency epidemiology and demographics
Insulinoma diagnostic criteria